0001567619-20-017365.txt : 20201001 0001567619-20-017365.hdr.sgml : 20201001 20201001165412 ACCESSION NUMBER: 0001567619-20-017365 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200929 FILED AS OF DATE: 20201001 DATE AS OF CHANGE: 20201001 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HEALY JAMES CENTRAL INDEX KEY: 0001245624 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36721 FILM NUMBER: 201216833 MAIL ADDRESS: STREET 1: 3000 SAND HILL ROAD, 4-250 CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Coherus BioSciences, Inc. CENTRAL INDEX KEY: 0001512762 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 273615821 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: C/O DENNIS M. LANFEAR STREET 2: 333 TWIN DOLPHIN DR, SUITE 600 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: (650) 649-3530 MAIL ADDRESS: STREET 1: C/O DENNIS M. LANFEAR STREET 2: 333 TWIN DOLPHIN DR, SUITE 600 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FORMER COMPANY: FORMER CONFORMED NAME: BioGenerics, Inc. DATE OF NAME CHANGE: 20110210 4 1 doc1.xml FORM 4 X0306 4 2020-09-29 0 0001512762 Coherus BioSciences, Inc. CHRS 0001245624 HEALY JAMES C/O SOFINNOVA INVESTMENTS, INC. 3000 SAND HILL ROAD, BLDG. 4, SUITE 250 MENLO PARK CA 94025 1 0 0 0 Common Stock, $0.0001 par value 2020-09-29 4 J 0 950000 0.00 D 0 I See Footnote Common Stock, $0.0001 par value 2020-09-29 4 J 0 213546 0.00 A 434555 I See Footnote Common Stock, $0.0001 par value 70086 D Sofinnova Venture Partners VII, L.P. distributed an aggregate of 950,000 shares of common stock of the issuer to its limited and general partners for no consideration on September 29, 2020. Includes pro rata allocation of such shares distributed to Sofinnova Management VII, LLC. The shares are held by Sofinnova Venture Partners VII, L.P. The Reporting Person is one of the managing members of the general partner of Sofinnova Venture Partners VII, L.P., and as such, may be deemed to share voting and investment power with respect to such securities. The Reporting Person disclaims beneficial ownership of the reported securities, except to the extent of his proportionate pecuniary interest in Sofinnova Ventures Partners VII, L.P. The shares are held by Sofinnova Management VII, LLC. The Reporting Person disclaims beneficial ownership of the reported securities, except to the extent of his proportionate pecuniary interest in Sofinnova Management VII, LLC. /s/ Jean-Frederic Viret, as Attorney-in-Fact for James I. Healy, M.D., Ph.D. 2020-10-01